Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.83% | -0.76% | 1.37% | 1.36% | 1.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.83% | -0.76% | 1.37% | 1.36% | 1.36% |
| Cost of Revenue | -5.25% | -5.00% | -4.75% | -6.53% | -8.20% |
| Gross Profit | -1.30% | 2.05% | 5.59% | 7.05% | 8.55% |
| SG&A Expenses | 3.54% | 9.77% | 16.80% | 20.15% | 23.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 97.87% | 55.23% | 20.43% | -33.34% | -59.81% |
| Total Operating Expenses | 0.05% | 2.57% | 5.19% | 4.57% | 3.95% |
| Operating Income | -27.22% | -26.69% | -26.22% | -21.09% | -16.26% |
| Income Before Tax | -12.36% | -19.45% | -25.73% | -20.77% | -16.08% |
| Income Tax Expenses | -10.80% | -2.81% | 6.67% | 3.99% | 1.68% |
| Earnings from Continuing Operations | -12.56% | -21.27% | -28.74% | -23.21% | -17.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -160.19% | -475.37% | -3,461.61% | -2,656.44% | -1,654.44% |
| Net Income | -20.23% | -30.41% | -38.74% | -29.98% | -21.59% |
| EBIT | -27.22% | -26.69% | -26.22% | -21.09% | -16.26% |
| EBITDA | -18.08% | -17.20% | -16.38% | -14.14% | -12.03% |
| EPS Basic | -20.47% | -30.57% | -38.83% | -30.13% | -21.81% |
| Normalized Basic EPS | -35.62% | -38.45% | -40.78% | -31.03% | -21.81% |
| EPS Diluted | -20.36% | -30.48% | -38.76% | -30.25% | -21.93% |
| Normalized Diluted EPS | -35.34% | -38.21% | -40.57% | -30.97% | -21.89% |
| Average Basic Shares Outstanding | 0.21% | 0.22% | 0.23% | 0.23% | 0.24% |
| Average Diluted Shares Outstanding | 0.00% | -0.01% | -0.02% | 0.16% | 0.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.13% | 0.45% | 0.84% | 0.61% | 0.44% |